Loading…

Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2—Artificial Intelligence Analytics

To validate the performance of the Notal OCT Analyzer (NOA) in processing self-administered OCT images from an OCT system designed for home use (home OCT [HOCT]) as part of a pivotal study aimed at achieving de novo United States Food and Drug Admininstration marketing authorization. A prospective q...

Full description

Saved in:
Bibliographic Details
Published in:Ophthalmology science (Online) 2025-03, Vol.5 (2), p.100662, Article 100662
Main Authors: Schneider, Eric W., Heier, Jeffrey S., Holekamp, Nancy M., Busquets, Miguel A., Wagner, Alan L., Mukkamala, S. Krishna, Riemann, Christopher D., Lee, Seong Y., Joondeph, Brian C., Houston, Steven S., Nahen, Kester, Mohan, Nishant, Benyamini, Gidi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c359t-1934bbf44ff0d0f96c0ec4593fd274a723c49c01462496631502ae1e3acbeab13
container_end_page
container_issue 2
container_start_page 100662
container_title Ophthalmology science (Online)
container_volume 5
creator Schneider, Eric W.
Heier, Jeffrey S.
Holekamp, Nancy M.
Busquets, Miguel A.
Wagner, Alan L.
Mukkamala, S. Krishna
Riemann, Christopher D.
Lee, Seong Y.
Joondeph, Brian C.
Houston, Steven S.
Nahen, Kester
Mohan, Nishant
Benyamini, Gidi
description To validate the performance of the Notal OCT Analyzer (NOA) in processing self-administered OCT images from an OCT system designed for home use (home OCT [HOCT]) as part of a pivotal study aimed at achieving de novo United States Food and Drug Admininstration marketing authorization. A prospective quantitative cross-sectional artificial intelligence study. The study enrolled adults aged ≥55 years diagnosed with neovascular age-related macular degeneration (nAMD) in ≥1 eligible eye with a best-corrected visual acuity of 20/320 or better. Participants self-imaged 4 times on each of 2 HOCT devices and once with an in-office OCT (IO-OCT) device during a single visit. Scans were segmented by the NOA and human graders at a certified reading center (RC). Intradevice and interdevice repeatability and reproducibility of total retinal hyporeflective (TRO) volume estimation by the NOA on HOCT-acquired images as compared with that of RC graders on IO-OCT-acquired images. Additionally, to assess the performance of the NOA in segmentation of TRO over multiple B-scans as compared with RC graders. Self-imaging was performed successfully by 387 participants in 2451 of 2616 attempts (93.7%). For repeatability, the coefficient of variance for NOA was 11.1% for eyes with >10 volume units of TRO imaged with HOCT compared with 16.4% for RC graders segmenting IO-OCT images. The median DICE similarity coefficients for segmentation of TRO by NOA vs. Grader 1, Grader 2, and Grader 3; Grader 1 vs. Grader 2 and Grader 3; and Grader 2 vs. Grader 3 were 0.68, 0.68, 0.61, 0.72, 0.63, 0.70, respectively. The performance of NOA supports the intended use of the system as a tool to monitor TRO at home between routine clinical visits in support of the management of nAMD. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
doi_str_mv 10.1016/j.xops.2024.100662
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_10979396f40f4457a864240a0268ee13</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2666914524001982</els_id><doaj_id>oai_doaj_org_article_10979396f40f4457a864240a0268ee13</doaj_id><sourcerecordid>3155718341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-1934bbf44ff0d0f96c0ec4593fd274a723c49c01462496631502ae1e3acbeab13</originalsourceid><addsrcrecordid>eNp9kstuEzEUhkcIRKvSF2CBZslmgm_jiSUkFKWFRioUQVhbJ57j4GgyDrYT6I6H6IbX40nwMKVqN2xs61y-8-v4L4rnlEwoofLVZvLD7-KEESZygEjJHhXHTEpZKSrqx_feR8VpjBtCCKspZ4I-LY64mlLKZH1c_ProDj5BVy6DG07_HUJbnluLJrkD9hhj6W35GTtbQbt1vYsJA7bl1XxZur78gP4A0ew7COVsjVXADlJOv4cxdobrDAmQnO8n5Sfc-ZBK9vvnzSwkZ50Zhi76hF3ncqHBctZDd52cic-KJxa6iKe390nx5e35cn5RXV69W8xnl5XhtUoVVVysVlYIa0lLrJKGoBG14rZljYCGcSOUIVRIJpSUnNaEAVLkYFYIK8pPisXIbT1s9C64LYRr7cHpvwEf1hqyVtOhpkQ1iitpBckD6wamUjBBgDA5RaQ8s96MrN1-tcXWYJ8CdA-gDzO9-6rX_qApbTgV04Hw8pYQ_Lc9xqS3Lpq8HujR76PO-uuGTrkYhLOx1AQfY0B7N4cSPXhEb_TgET14RI8eyU0v7iu8a_nniFzweizAvPODw6CjccPPtC5kT-SluP_x_wCbKs_w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3155718341</pqid></control><display><type>article</type><title>Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2—Artificial Intelligence Analytics</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Schneider, Eric W. ; Heier, Jeffrey S. ; Holekamp, Nancy M. ; Busquets, Miguel A. ; Wagner, Alan L. ; Mukkamala, S. Krishna ; Riemann, Christopher D. ; Lee, Seong Y. ; Joondeph, Brian C. ; Houston, Steven S. ; Nahen, Kester ; Mohan, Nishant ; Benyamini, Gidi</creator><creatorcontrib>Schneider, Eric W. ; Heier, Jeffrey S. ; Holekamp, Nancy M. ; Busquets, Miguel A. ; Wagner, Alan L. ; Mukkamala, S. Krishna ; Riemann, Christopher D. ; Lee, Seong Y. ; Joondeph, Brian C. ; Houston, Steven S. ; Nahen, Kester ; Mohan, Nishant ; Benyamini, Gidi</creatorcontrib><description>To validate the performance of the Notal OCT Analyzer (NOA) in processing self-administered OCT images from an OCT system designed for home use (home OCT [HOCT]) as part of a pivotal study aimed at achieving de novo United States Food and Drug Admininstration marketing authorization. A prospective quantitative cross-sectional artificial intelligence study. The study enrolled adults aged ≥55 years diagnosed with neovascular age-related macular degeneration (nAMD) in ≥1 eligible eye with a best-corrected visual acuity of 20/320 or better. Participants self-imaged 4 times on each of 2 HOCT devices and once with an in-office OCT (IO-OCT) device during a single visit. Scans were segmented by the NOA and human graders at a certified reading center (RC). Intradevice and interdevice repeatability and reproducibility of total retinal hyporeflective (TRO) volume estimation by the NOA on HOCT-acquired images as compared with that of RC graders on IO-OCT-acquired images. Additionally, to assess the performance of the NOA in segmentation of TRO over multiple B-scans as compared with RC graders. Self-imaging was performed successfully by 387 participants in 2451 of 2616 attempts (93.7%). For repeatability, the coefficient of variance for NOA was 11.1% for eyes with &gt;10 volume units of TRO imaged with HOCT compared with 16.4% for RC graders segmenting IO-OCT images. The median DICE similarity coefficients for segmentation of TRO by NOA vs. Grader 1, Grader 2, and Grader 3; Grader 1 vs. Grader 2 and Grader 3; and Grader 2 vs. Grader 3 were 0.68, 0.68, 0.61, 0.72, 0.63, 0.70, respectively. The performance of NOA supports the intended use of the system as a tool to monitor TRO at home between routine clinical visits in support of the management of nAMD. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</description><identifier>ISSN: 2666-9145</identifier><identifier>EISSN: 2666-9145</identifier><identifier>DOI: 10.1016/j.xops.2024.100662</identifier><identifier>PMID: 39811265</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Age-related macular degeneration ; Artificial intelligence ; Home OCT ; Neovascular ; Original ; Telemedicine</subject><ispartof>Ophthalmology science (Online), 2025-03, Vol.5 (2), p.100662, Article 100662</ispartof><rights>2024 American Academy of Ophthalmology</rights><rights>2024 by the American Academy of Ophthalmologyé.</rights><rights>2024 by the American Academy of Ophthalmologyé. 2024 American Academy of Ophthalmology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c359t-1934bbf44ff0d0f96c0ec4593fd274a723c49c01462496631502ae1e3acbeab13</cites><orcidid>0000-0003-4496-8462</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731483/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2666914524001982$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,3536,27901,27902,45756,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39811265$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneider, Eric W.</creatorcontrib><creatorcontrib>Heier, Jeffrey S.</creatorcontrib><creatorcontrib>Holekamp, Nancy M.</creatorcontrib><creatorcontrib>Busquets, Miguel A.</creatorcontrib><creatorcontrib>Wagner, Alan L.</creatorcontrib><creatorcontrib>Mukkamala, S. Krishna</creatorcontrib><creatorcontrib>Riemann, Christopher D.</creatorcontrib><creatorcontrib>Lee, Seong Y.</creatorcontrib><creatorcontrib>Joondeph, Brian C.</creatorcontrib><creatorcontrib>Houston, Steven S.</creatorcontrib><creatorcontrib>Nahen, Kester</creatorcontrib><creatorcontrib>Mohan, Nishant</creatorcontrib><creatorcontrib>Benyamini, Gidi</creatorcontrib><title>Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2—Artificial Intelligence Analytics</title><title>Ophthalmology science (Online)</title><addtitle>Ophthalmol Sci</addtitle><description>To validate the performance of the Notal OCT Analyzer (NOA) in processing self-administered OCT images from an OCT system designed for home use (home OCT [HOCT]) as part of a pivotal study aimed at achieving de novo United States Food and Drug Admininstration marketing authorization. A prospective quantitative cross-sectional artificial intelligence study. The study enrolled adults aged ≥55 years diagnosed with neovascular age-related macular degeneration (nAMD) in ≥1 eligible eye with a best-corrected visual acuity of 20/320 or better. Participants self-imaged 4 times on each of 2 HOCT devices and once with an in-office OCT (IO-OCT) device during a single visit. Scans were segmented by the NOA and human graders at a certified reading center (RC). Intradevice and interdevice repeatability and reproducibility of total retinal hyporeflective (TRO) volume estimation by the NOA on HOCT-acquired images as compared with that of RC graders on IO-OCT-acquired images. Additionally, to assess the performance of the NOA in segmentation of TRO over multiple B-scans as compared with RC graders. Self-imaging was performed successfully by 387 participants in 2451 of 2616 attempts (93.7%). For repeatability, the coefficient of variance for NOA was 11.1% for eyes with &gt;10 volume units of TRO imaged with HOCT compared with 16.4% for RC graders segmenting IO-OCT images. The median DICE similarity coefficients for segmentation of TRO by NOA vs. Grader 1, Grader 2, and Grader 3; Grader 1 vs. Grader 2 and Grader 3; and Grader 2 vs. Grader 3 were 0.68, 0.68, 0.61, 0.72, 0.63, 0.70, respectively. The performance of NOA supports the intended use of the system as a tool to monitor TRO at home between routine clinical visits in support of the management of nAMD. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</description><subject>Age-related macular degeneration</subject><subject>Artificial intelligence</subject><subject>Home OCT</subject><subject>Neovascular</subject><subject>Original</subject><subject>Telemedicine</subject><issn>2666-9145</issn><issn>2666-9145</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kstuEzEUhkcIRKvSF2CBZslmgm_jiSUkFKWFRioUQVhbJ57j4GgyDrYT6I6H6IbX40nwMKVqN2xs61y-8-v4L4rnlEwoofLVZvLD7-KEESZygEjJHhXHTEpZKSrqx_feR8VpjBtCCKspZ4I-LY64mlLKZH1c_ProDj5BVy6DG07_HUJbnluLJrkD9hhj6W35GTtbQbt1vYsJA7bl1XxZur78gP4A0ew7COVsjVXADlJOv4cxdobrDAmQnO8n5Sfc-ZBK9vvnzSwkZ50Zhi76hF3ncqHBctZDd52cic-KJxa6iKe390nx5e35cn5RXV69W8xnl5XhtUoVVVysVlYIa0lLrJKGoBG14rZljYCGcSOUIVRIJpSUnNaEAVLkYFYIK8pPisXIbT1s9C64LYRr7cHpvwEf1hqyVtOhpkQ1iitpBckD6wamUjBBgDA5RaQ8s96MrN1-tcXWYJ8CdA-gDzO9-6rX_qApbTgV04Hw8pYQ_Lc9xqS3Lpq8HujR76PO-uuGTrkYhLOx1AQfY0B7N4cSPXhEb_TgET14RI8eyU0v7iu8a_nniFzweizAvPODw6CjccPPtC5kT-SluP_x_wCbKs_w</recordid><startdate>20250301</startdate><enddate>20250301</enddate><creator>Schneider, Eric W.</creator><creator>Heier, Jeffrey S.</creator><creator>Holekamp, Nancy M.</creator><creator>Busquets, Miguel A.</creator><creator>Wagner, Alan L.</creator><creator>Mukkamala, S. Krishna</creator><creator>Riemann, Christopher D.</creator><creator>Lee, Seong Y.</creator><creator>Joondeph, Brian C.</creator><creator>Houston, Steven S.</creator><creator>Nahen, Kester</creator><creator>Mohan, Nishant</creator><creator>Benyamini, Gidi</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4496-8462</orcidid></search><sort><creationdate>20250301</creationdate><title>Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2—Artificial Intelligence Analytics</title><author>Schneider, Eric W. ; Heier, Jeffrey S. ; Holekamp, Nancy M. ; Busquets, Miguel A. ; Wagner, Alan L. ; Mukkamala, S. Krishna ; Riemann, Christopher D. ; Lee, Seong Y. ; Joondeph, Brian C. ; Houston, Steven S. ; Nahen, Kester ; Mohan, Nishant ; Benyamini, Gidi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-1934bbf44ff0d0f96c0ec4593fd274a723c49c01462496631502ae1e3acbeab13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Age-related macular degeneration</topic><topic>Artificial intelligence</topic><topic>Home OCT</topic><topic>Neovascular</topic><topic>Original</topic><topic>Telemedicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneider, Eric W.</creatorcontrib><creatorcontrib>Heier, Jeffrey S.</creatorcontrib><creatorcontrib>Holekamp, Nancy M.</creatorcontrib><creatorcontrib>Busquets, Miguel A.</creatorcontrib><creatorcontrib>Wagner, Alan L.</creatorcontrib><creatorcontrib>Mukkamala, S. Krishna</creatorcontrib><creatorcontrib>Riemann, Christopher D.</creatorcontrib><creatorcontrib>Lee, Seong Y.</creatorcontrib><creatorcontrib>Joondeph, Brian C.</creatorcontrib><creatorcontrib>Houston, Steven S.</creatorcontrib><creatorcontrib>Nahen, Kester</creatorcontrib><creatorcontrib>Mohan, Nishant</creatorcontrib><creatorcontrib>Benyamini, Gidi</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Ophthalmology science (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneider, Eric W.</au><au>Heier, Jeffrey S.</au><au>Holekamp, Nancy M.</au><au>Busquets, Miguel A.</au><au>Wagner, Alan L.</au><au>Mukkamala, S. Krishna</au><au>Riemann, Christopher D.</au><au>Lee, Seong Y.</au><au>Joondeph, Brian C.</au><au>Houston, Steven S.</au><au>Nahen, Kester</au><au>Mohan, Nishant</au><au>Benyamini, Gidi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2—Artificial Intelligence Analytics</atitle><jtitle>Ophthalmology science (Online)</jtitle><addtitle>Ophthalmol Sci</addtitle><date>2025-03-01</date><risdate>2025</risdate><volume>5</volume><issue>2</issue><spage>100662</spage><pages>100662-</pages><artnum>100662</artnum><issn>2666-9145</issn><eissn>2666-9145</eissn><abstract>To validate the performance of the Notal OCT Analyzer (NOA) in processing self-administered OCT images from an OCT system designed for home use (home OCT [HOCT]) as part of a pivotal study aimed at achieving de novo United States Food and Drug Admininstration marketing authorization. A prospective quantitative cross-sectional artificial intelligence study. The study enrolled adults aged ≥55 years diagnosed with neovascular age-related macular degeneration (nAMD) in ≥1 eligible eye with a best-corrected visual acuity of 20/320 or better. Participants self-imaged 4 times on each of 2 HOCT devices and once with an in-office OCT (IO-OCT) device during a single visit. Scans were segmented by the NOA and human graders at a certified reading center (RC). Intradevice and interdevice repeatability and reproducibility of total retinal hyporeflective (TRO) volume estimation by the NOA on HOCT-acquired images as compared with that of RC graders on IO-OCT-acquired images. Additionally, to assess the performance of the NOA in segmentation of TRO over multiple B-scans as compared with RC graders. Self-imaging was performed successfully by 387 participants in 2451 of 2616 attempts (93.7%). For repeatability, the coefficient of variance for NOA was 11.1% for eyes with &gt;10 volume units of TRO imaged with HOCT compared with 16.4% for RC graders segmenting IO-OCT images. The median DICE similarity coefficients for segmentation of TRO by NOA vs. Grader 1, Grader 2, and Grader 3; Grader 1 vs. Grader 2 and Grader 3; and Grader 2 vs. Grader 3 were 0.68, 0.68, 0.61, 0.72, 0.63, 0.70, respectively. The performance of NOA supports the intended use of the system as a tool to monitor TRO at home between routine clinical visits in support of the management of nAMD. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>39811265</pmid><doi>10.1016/j.xops.2024.100662</doi><orcidid>https://orcid.org/0000-0003-4496-8462</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2666-9145
ispartof Ophthalmology science (Online), 2025-03, Vol.5 (2), p.100662, Article 100662
issn 2666-9145
2666-9145
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_10979396f40f4457a864240a0268ee13
source ScienceDirect Journals; PubMed Central
subjects Age-related macular degeneration
Artificial intelligence
Home OCT
Neovascular
Original
Telemedicine
title Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2—Artificial Intelligence Analytics
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A05%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pivotal%20Trial%20Toward%20Effectiveness%20of%20Self-administered%20OCT%20in%20Neovascular%20Age-related%20Macular%20Degeneration.%20Report%202%E2%80%94Artificial%20Intelligence%20Analytics&rft.jtitle=Ophthalmology%20science%20(Online)&rft.au=Schneider,%20Eric%20W.&rft.date=2025-03-01&rft.volume=5&rft.issue=2&rft.spage=100662&rft.pages=100662-&rft.artnum=100662&rft.issn=2666-9145&rft.eissn=2666-9145&rft_id=info:doi/10.1016/j.xops.2024.100662&rft_dat=%3Cproquest_doaj_%3E3155718341%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-1934bbf44ff0d0f96c0ec4593fd274a723c49c01462496631502ae1e3acbeab13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3155718341&rft_id=info:pmid/39811265&rfr_iscdi=true